✦ LIBER ✦

On the electrochemical oxidation of 5-hydroxy barbituric acid

✍ Scribed by Sheela Berchmans; R. Vijayavalli

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 419 KB
Volume: 6
Category: Article
ISSN: 1040-0397
DOI: 10.1002/elan.1140061125

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Electrochemical oxidation of 5-hydroxytr

Electrochemical oxidation of 5-hydroxytryptophan in acid solution

✍ Keith Humphries; Glenn Dryhurst 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 916 KB

ChemInform Abstract: Preparation of 5-(C

ChemInform Abstract: Preparation of 5-(Cyclohexylmethyl)barbituric Acid Derivatives by Acid-Catalyzed Reductive Cyclohexylmethylation of Barbituric Acids with p-Hydroxy or p-Methoxybenzaldehydes.

✍ Donna M. Neumann; Branko S. Jursic; Kenneth L. Martin 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB

Electrochemical oxidation of 5-hydroxytr

Electrochemical oxidation of 5-hydroxytryptophol. I: Studies in acid solution

✍ Fu-Chou Cheng; Glenn Dryhurst 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 776 KB

On the Electrochemical Oxidation of Resv

On the Electrochemical Oxidation of Resveratrol

✍ Oana Corduneanu; Patricia Janeiro; Ana Maria Oliveira Brett 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB

The Dissociation Constants of Some 1,5,5

The Dissociation Constants of Some 1,5,5-Trisubstituted Barbituric Acids

✍ Jerzy L. Mokrosz; Jacek Bojarski; Wacław Wełna 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB 👁 2 views

Treatment of essential tremor with the b

Treatment of essential tremor with the barbiturate t2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid)

✍ Calvin Melmed; Daniel Moros; Howard Rutman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract The effect of the barbiturate T2000 (1,3‐dimethoxymethyl‐5,5‐diphenyl‐barbituric acid; DMMDPB) on essential tremor, given in twice daily doses of 400 and 300 mg, was assessed in two brief, randomized, placebo‐controlled, parallel‐group, double‐blinded, single‐center trials in 12 and 22